申请人:The Regents of the University of California
公开号:US20150011575A1
公开(公告)日:2015-01-08
Disclosed herein are, inter alia, compositions for modulating Ire1, Src, or Abl, methods for identifying modulating activity in test compounds, and methods for treating diseases caused by the activity or inactivity of Ire1, Src, or Abl.
本文披露了调节Ire1、Src或Abl的组合物,用于识别试验化合物中的调节活性的方法,以及治疗由Ire1、Src或Abl的活性或不活性引起的疾病的方法。